New Long-Lasting treatment tested for hemophilia b in china
NCT ID NCT06399289
Summary
This study is testing a long-acting clotting factor medicine (rIX-FP) for Chinese males with hemophilia B. The goal is to see how well it prevents bleeding episodes when used regularly, and how it works to treat bleeds that happen anyway. Researchers will measure how long the medicine lasts in the body, how safe it is, and how effective it is at controlling bleeding.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, 550004, China
-
Beijing Children's Hospital
Beijing, Beijing Municipality, 100045, China
-
Hospital of Hematology, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, 300020, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
-
North China University Of Science And Technology Affiliated Hospital
Tangshan, Hebei, 63000, China
-
Union Hospital Affiliated to Fujian Medical University
Fuzhou, Fujian, 350001, China
Conditions
Explore the condition pages connected to this study.